Royalty Pharma prices $6 billion bond deal that is its first as a public companyMarket Watch • 08/25/20
Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20
Applied Materials, Barrick, Cisco, DraftKings and More Major Earnings Coming This Week24/7 Wall Street • 08/09/20
Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 MillionPRNewsWire • 08/07/20
5 Large Biotechs and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-1924/7 Wall Street • 08/05/20
Royalty Pharma to Announce Second-Quarter 2020 Financial Results on August 12GlobeNewsWire • 07/20/20